BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 16329568)

  • 1. Leprosy in Malaysia.
    Jayalakshmi P
    Malays J Pathol; 1994 Jun; 16(1):7-9. PubMed ID: 16329568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer drugs in leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
    WHO Regional Office for South-East Asia
    Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An appraisal of medical research in the treatment and control of leprosy.
    Rees RJ
    Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for newer antileprosy drugs.
    Dhople AM
    Indian J Lepr; 2000; 72(1):5-20. PubMed ID: 10935183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 13. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
    Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The debate over leprosy elimination versus sustainability of leprosy services.
    Indian J Lepr; 2005; 77(4):299-304. PubMed ID: 16465825
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment].
    Ferracci C; Baquillon G; Pattyn SR
    Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
    World Health Organization
    Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
    [No Abstract]   [Full Text] [Related]  

  • 19. Taking home lessons from the 15th International Leprosy Congress.
    Lechat MF
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):562-6. PubMed ID: 10347572
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
    Sreevatsa ; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.